Tiziana Rancati
University of Milan
CancerInternal medicineRadiologyUrologySurgeryOncologyProspective cohort studyCohort studyProstateAbdominal surgeryProstate cancerRectumPopulationToxicityNuclear medicineIn patientRadiation therapyBreast cancerMedicineCohortUrinary systemGastroenterology
301Publications
27H-index
2,478Citations
Publications 300
Newest
#1Tiziana RancatiH-Index: 27
#2C. FiorinoH-Index: 7
The treatment of a patient with radiation therapy is planned to find the optimal way to treat a tumour while minimizing the dose received by the surrounding normal tissues. In order to better exploit the possibilities of this process, the availability of accurate and quantitative knowledge of the peculiar responses of the different tissues is of paramount importance. This book provides an invaluable tutorial for radiation oncologists, medical physicists, and dosimetrists involved in the planning...
#1Tiziana RancatiH-Index: 27
#2C. FiorinoH-Index: 7
Source
#1Theo van der Kwast (UHN: University Health Network)H-Index: 21
#1Theo H. van der Kwast (UHN: University Health Network)H-Index: 61
Last. Sophie Bruinsma (EUR: Erasmus University Rotterdam)H-Index: 1
view all 73 authors...
Abstract Within the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) initiative, 25 centers across the globe collaborate to standardize active surveillance (AS) protocols for men with low-risk prostate cancer (PCa). A centralized PCa AS database, comprising data of more than 15000 patients worldwide, was created. Comparability of the histopathology between the different cohorts was assessed by a centralized pathology review of 445 biopsies from 15 GAP3 centers....
4 CitationsSource
#1Paolo GandelliniH-Index: 25
#2Nicola Casiraghi (University of Trento)H-Index: 7
Last. Nadia ZaffaroniH-Index: 66
view all 11 authors...
Abstract Background Genomic characterization of prostate cancer (PCa) biopsies may improve criteria for the selection of patients suitable for active surveillance (AS). Objective To identify somatic genomic aberrations associated with adverse outcome as AS protocol exclusion indicators. Design, setting and participants Whole-exome sequencing profiles were generated for Gleason score (GS) = 3 + 3 biopsies obtained from 54 PCa patients enrolled in two AS protocols. Patients were selected as repres...
1 CitationsSource
#1Elisa ScalcoH-Index: 11
#2Tiziana RancatiH-Index: 27
Last. Giovanna RizzoH-Index: 35
view all 7 authors...
Source
#1Catharine M L WestH-Index: 77
#2David AzriaH-Index: 56
Last. A WebbH-Index: 9
view all 13 authors...
Source
#1Fernando MunozH-Index: 18
#2Domenico CanteH-Index: 16
Last. Cesare CozzariniH-Index: 43
view all 25 authors...
Source
#1Giuseppe SanguinetiH-Index: 37
#2Domenico CanteH-Index: 16
Last. Cesare CozzariniH-Index: 43
view all 25 authors...
Source
#1Anna CavalloH-Index: 7
Last. E. OrlandiH-Index: 3
view all 17 authors...
Source
#1Pietro GabrieleH-Index: 23
#2Fernando MunozH-Index: 18
Last. Cesare CozzariniH-Index: 43
view all 24 authors...
Source